FDA Hearing on Off-Labels Use of Devices Explores Risks to Patients

Star Tribune, November 10, 2016. NCHR President Diana Zuckerman said the Infuse Bone Graft is “contraindicated” for children. But the FDA’s 2015 warning didn’t ban the product in kids because some children have such significant bone defects or such rare bone disorders that they would be willing to accept the risks.

Read More »

Trump Just Dropped a Big Hint to the Pharmaceutical Industry

Washington Post, November 14, 2016. “I think the honest answer is nobody knows” what to expect, said Diana Zuckerman, president of the National Center for Health Research. “Some members of Congress owe pharma a favor; we don’t know the Trump campaign is in that position, and they might not be — and that might give them a certain amount of flexibility. The Trump campaign is nothing if not iconoclastic.”

Read More »

Obamacare on the Chopping Block?

MedPage Today, November 9, 2016. “I’m not sure what will happen to the Affordable Care Act.” NCHR President Diana Zuckerman noted that full repeal of Obamacare would be hard with so many people now relying on it, many of whom live in red states.

Read More »

Actress Elisabeth Rohm Joins the Fight Against Cancer

November 8, 2016. We were thrilled when Elisabeth Rohm enthusiastically agreed to film a public service announcement for the Cancer Prevention and Treatment Fund. She is particularly interested in our unique work to prevent cancer and keeping cancer-causing chemicals out of children’s products as well as our food, homes, and neighborhoods.

Read More »